453 related articles for article (PubMed ID: 22721390)
1. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents.
Mohamed MF; Mohamed MS; Shouman SA; Fathi MM; Abdelhamid IA
Appl Biochem Biotechnol; 2012 Nov; 168(5):1153-62. PubMed ID: 22948604
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.
Dyrager C; Wickström M; Fridén-Saxin M; Friberg A; Dahlén K; Wallén EA; Gullbo J; Grøtli M; Luthman K
Bioorg Med Chem; 2011 Apr; 19(8):2659-65. PubMed ID: 21459004
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
Gibson MZ; Nguyen MA; Zingales SK
Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
6. Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin.
Dias TA; Duarte CL; Lima CF; Proença MF; Pereira-Wilson C
Eur J Med Chem; 2013 Jul; 65():500-10. PubMed ID: 23771043
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Active Heterocyclic Chalcones: Recent Developments.
Dandawate P; Ahmed K; Padhye S; Ahmad A; Biersack B
Anticancer Agents Med Chem; 2021; 21(5):558-566. PubMed ID: 32628595
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and identification of α-cyano bis(indolyl)chalcones as novel anticancer agents.
Kumar D; Maruthi Kumar N; Tantak MP; Ogura M; Kusaka E; Ito T
Bioorg Med Chem Lett; 2014 Nov; 24(22):5170-4. PubMed ID: 25442306
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxicity evaluation of biaryl-based chalcones and their potential in TNFα-induced nuclear factor-κB activation inhibition.
Zuo Y; Yu Y; Wang S; Shao W; Zhou B; Lin L; Luo Z; Huang R; Du J; Bu X
Eur J Med Chem; 2012 Apr; 50():393-404. PubMed ID: 22386368
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents.
Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS
Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of methoxy-substituted chalcones and in vitro evaluation of their anticancer potential.
Ethiraj KR; Aranjani JM; Khan FR
Chem Biol Drug Des; 2013 Dec; 82(6):732-42. PubMed ID: 23834620
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
13. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
14. Replacement of the double bond of antitubulin chalcones with triazoles and tetrazoles: Synthesis and biological evaluation.
Mesenzani O; Massarotti A; Giustiniano M; Pirali T; Bevilacqua V; Caldarelli A; Canonico P; Sorba G; Novellino E; Genazzani AA; Tron GC
Bioorg Med Chem Lett; 2011 Jan; 21(2):764-8. PubMed ID: 21167709
[TBL] [Abstract][Full Text] [Related]
15. Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications.
Mahapatra DK; Bharti SK; Asati V; Singh SK
Eur J Med Chem; 2019 Jul; 174():142-158. PubMed ID: 31035237
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anticancer and antioxidant activities of 2,4,5-trimethoxy chalcones and analogues from asaronaldehyde: structure-activity relationship.
Shenvi S; Kumar K; Hatti KS; Rijesh K; Diwakar L; Reddy GC
Eur J Med Chem; 2013 Apr; 62():435-42. PubMed ID: 23395966
[TBL] [Abstract][Full Text] [Related]
17. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.
Mai CW; Yaeghoobi M; Abd-Rahman N; Kang YB; Pichika MR
Eur J Med Chem; 2014 Apr; 77():378-87. PubMed ID: 24675137
[TBL] [Abstract][Full Text] [Related]
18. Chromenylchalcones showing cytotoxicity on human colon cancer cell lines and in silico docking with aurora kinases.
Shin SY; Yoon H; Ahn S; Kim DW; Kim SH; Koh D; Lee YH; Lim Y
Bioorg Med Chem; 2013 Jul; 21(14):4250-8. PubMed ID: 23719279
[TBL] [Abstract][Full Text] [Related]
19. Chalcone Derivatives: Role in Anticancer Therapy.
Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic events induced by synthetic naphthylchalcones in human acute leukemia cell lines.
Maioral MF; Gaspar PC; Rosa Souza GR; Mascarello A; Chiaradia LD; Licínio MA; Moraes AC; Yunes RA; Nunes RJ; Santos-Silva MC
Biochimie; 2013 Apr; 95(4):866-74. PubMed ID: 23257665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]